CTXR logoCTXR
Citius Pharmaceuticals Inc

21,685
Loading...
Loading...
News
all
press releases
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and...
PR Newswire·7mo ago
News Placeholder
More News
News Placeholder
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services Citius Pharmaceuticals and Citius Oncology Announce Unique...
PR Newswire·8mo ago
News Placeholder
Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced...
PR Newswire·9mo ago
News Placeholder
Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025
Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025 Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch...
PR Newswire·9mo ago
News Placeholder
Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives
Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives...
PR Newswire·9mo ago
News Placeholder
Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital
Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital...
Yahoo! Finance: News·9mo ago
News Placeholder
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides...
PR Newswire·9mo ago
News Placeholder
Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok Program and Pathway to Approval
Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok Program and Pathway to Approval Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase...
PR Newswire·10mo ago
News Placeholder
Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split
Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split PR Newswire CRANFORD, N.J., Nov. 22, 2024 CRANFORD, N.J., Nov...
PR Newswire·10mo ago
News Placeholder
Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering
Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering PR Newswire CRANFORD, N.J., Nov...
PR Newswire·10mo ago

Latest CTXR News

View

Advertisement. Remove ads.

Advertisement. Remove ads.